Skip to main content
Press Release

Santa Fe duo appears in court on firearm and drug trafficking charges

For Immediate Release
U.S. Attorney's Office, District of New Mexico

ALBUQUERQUE, N.M. – Werni Lopez-Perez, 25, and Mario Guizar-Anchondo, 19, both of Santa Fe, New Mexico, made an initial appearance in federal court today, facing charges of conspiracy, possession with the intent to distribute 400 grams and more of fentanyl, possession with the intent to distribute 500 grams and more of a mixture and substance containing methamphetamine and possessing a firearm in furtherance of a drug trafficking crime. They will remain in custody pending an arraignment and detention hearing scheduled for Jan. 27.

Lopez-Perez and Guizar-Anchondo were indicted on Jan. 11. According to the indictment and other court records, on Dec. 30, 2021, Guizar-Anchondo allegedly was driving and Lopez-Perez allegedly was a passenger in a pickup truck when Santa Fe police performed a traffic stop for nonfunctioning tail lights. Neither Guizar-Anchondo nor Lopez-Perez had a valid driver license and the officer informed them the truck would be impounded. During a subsequent search of the truck, investigators allegedly recovered approximately 1,730.7 grams of methamphetamine, approximately 3,401.5 grams of fentanyl, five loaded firearms, and $5,563 in cash.

An indictment is only an allegation. A defendant is considered innocent unless and until proven guilty. If convicted on the drug charges, Lopez-Perez and Guizar-Anchondo face a minimum of 10 years and up to life in prison. If convicted on the firearm charge, they would face a consecutive 5 years and up to life in prison.

The Santa Fe Resident Agency of the FBI Albuquerque Field Office investigated this case with assistance from the U.S. Drug Enforcement Administration (DEA), Santa Fe Police Department, New Mexico State Police and Santa Fe County Sheriff’s Office. Assistant United States Attorney Louis Mattei is prosecuting the case.

Updated January 25, 2022

Drug Trafficking
Prescription Drugs
Press Release Number: 22-12